Expansion of the China business through the conversion of Alpha Corporation into a subsidiary
First written in FY2017-Q1. 3 of 6 entries say "Restated". Latest entry: FY2022.
No other company in this theme has enough history to compare yet.
- FY2022AdvancedAnnual report
「To achieve a stable supply of products in preparation for further sales growth, we strengthened investment in production expansion, including the establishment of a local production system.」
In the China orthokeratology business, including Alpha Corporation, we established a local production system and invested in expanding production. - FY2021RestatedAnnual report
「To meet further expected growth in demand for orthokeratology lenses, we established a new local entity in China as 株式会社アルファコーポレーション's new factory and are preparing it for operation.」
We continue to expand the orthokeratology business in China centered on Alpha Corporation and prepare for local production. - FY2021-Q3AdvancedAnnual report
「To meet growing demand, 株式会社アルファコーポレーション, which manufactures orthokeratology lenses for our group, established a local entity in China with the aim of beginning mass production in 2024.」
For Alpha Corporation's expansion in China, a local entity was established to meet growing demand, with a plan to begin mass production in 2024. - FY2018-Q3RestatedAnnual report
「Net sales in the contact lens-related business for the first nine months of the current fiscal year were ¥56,207 million, up 7.6% year on year, mainly due to an increase in Menicon Mels Plan members and the conversion of 株式会社エーアイピー into a consolidated subsidiary in the third quarter of the previous fiscal year.」
The conversion of エーアイピー into a consolidated subsidiary was again cited, together with the increase in Menicon Mels Plan members, as a factor behind higher sales in the contact lens-related business for the first nine months. - FY2018-Q1RestatedAnnual report
「Driven mainly by an increase in the number of Menicon Mels Plan members and the conversion of 株式会社エーアイピー into a consolidated subsidiary in the third quarter of the previous fiscal year, net sales for the first quarter of the current fiscal year were ¥18,306 million, up 8.6% year on year.」
The conversion of エーアイピー into a consolidated subsidiary was cited again as one of the factors behind sales in the contact lens-related business during the quarter. - FY2017-Q1First statedAnnual report
「In June, we made 株式会社アルファコーポレーション a subsidiary and will work to further expand our business base in China by selling orthokeratology lenses, the company's strength, which correct myopia when worn during sleep.」
In June 2016, we acquired all shares in the company and made it a consolidated subsidiary, using its orthokeratology business to expand in China.